id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-4643-0001,FDA,FDA-2026-N-4643,Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device,Rule,Final Rule,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T17:30:07Z,2026-08812,0,0,09000064b92c6687